Literature DB >> 9807117

Proteases of Porphyromonas gingivalis: what don't they do?

H K Kuramitsu1.   

Abstract

The gram-negative anaerobic bacterium Porphyromonas gingivalis has been strongly associated with the causation of human periodontal diseases. One distinguishing property of these organisms that has been implicated in periodontal destruction is the expression of potent protease activity. Recent biochemical and genetic approaches have clearly demonstrated that at least five distinct proteases are elaborated by these organisms. The utilization of monospecific mutants defective in individual proteases has demonstrated that protease activity is important in virulence but also has suggested the complexity of the functions of the enzymes in the physiology of these microorganisms. This review summarizes current progress in assessing the role of these enzymes in periodontal inflammation and discusses some unresolved issues relevant to the significance of P. gingivalis proteases in virulence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9807117     DOI: 10.1111/j.1399-302x.1998.tb00706.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  36 in total

1.  Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis.

Authors:  P L Yun; A A Decarlo; C Collyer; N Hunter
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Role of gingipains in growth of Porphyromonas gingivalis in the presence of human serum albumin.

Authors:  D Grenier; S Imbeault; P Plamondon; G Grenier; K Nakayama; D Mayrand
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.

Authors:  Dalia E Gaddis; Suzanne M Michalek; Jannet Katz
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

4.  Molecular mechanism for the spontaneous generation of pigmentless Porphyromonas gingivalis mutants.

Authors:  W Chen; H K Kuramitsu
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis.

Authors:  Dalia E Gaddis; Craig L Maynard; Casey T Weaver; Suzanne M Michalek; Jannet Katz
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

6.  Protein Analysis of Sapienic Acid-Treated Porphyromonas gingivalis Suggests Differential Regulation of Multiple Metabolic Pathways.

Authors:  Carol L Fischer; Deborah V Dawson; Derek R Blanchette; David R Drake; Philip W Wertz; Kim A Brogden
Journal:  J Bacteriol       Date:  2015-10-19       Impact factor: 3.490

7.  Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.

Authors:  M Kuboniwa; A Amano; S Shizukuishi; I Nakagawa; S Hamada
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of T-cell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases.

Authors:  Peter L W Yun; Arthur A DeCarlo; Charles Collyer; Neil Hunter
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Gingipain-dependent degradation of mammalian target of rapamycin pathway proteins by the periodontal pathogen Porphyromonas gingivalis during invasion.

Authors:  P Stafford; J Higham; A Pinnock; C Murdoch; C W I Douglas; G P Stafford; D W Lambert
Journal:  Mol Oral Microbiol       Date:  2013-05-29       Impact factor: 3.563

10.  Excreted/secreted proteins from trypanosome procyclic strains.

Authors:  Celestine Michelle Atyame Nten; Nicolas Sommerer; Valerie Rofidal; Christophe Hirtz; Michel Rossignol; Gerard Cuny; Jean-Benoit Peltier; Anne Geiger
Journal:  J Biomed Biotechnol       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.